Clinical Study on Patients with Bone Metastases – A Twelve Year Follow-up
Journal: Scholarena Journal of Cancer Science (Vol.5, No. 3)Publication Date: 2018-09-24
Authors : Leung PC Kumta SM Kong SL Au WC Cheng KF;
Page : 1-4
Keywords : Metastatic Cancer; Bone Secondaries; Herbal Treatment; Bisphosphonate;
Abstract
A clinical study on patients with metastatic bone cancer studied in 2003, comparing the results of treatment using clodronate (a bisphosphonate) and a herbal formula BBYNG. Detailed study extended for 72 weeks, after which some patients continued taking the herbal treatment while others were just kept connected.
12 years after the start of the clinical study, 8 patients were surviving well, 7 of them belonged to the herbal group. Working back on the 5 years survival since 2003, it is observed that the herbal group compared with the clodronate group was 69.4% vs 30.6%. The twelve years' follow-up might indicate that the herbal formula might have given better sustenance effects
Other Latest Articles
- Loco-Regional Recurrence after Conservative Breast Surgery Followed by Radiotherapy versus Mastectomy Alone for T1-2 and N0-1 under the Umbrella of Modern Adjuvant Chemotherapy
- Diagnosis Profile and Therapeutic of Hepatocellular Carcinoma (HC)
- Перше фундаментальне дослідження виникнення й становлення розшуку в Україні
- Науковий висновок
- Теоретико-праксеологічне дослідження проблем застосування заходів забезпечення кримінального провадження
Last modified: 2018-11-29 13:35:16